Alabama CON Report - June 2015 - Lexology (registration) |
- Certificate of Need Program
- AL2015-020:Bio-Medical Applications of Alabama, Inc., d/b/a Fresenius Medical Services of Taylor Road, Birmingham, AL, proposes to expand its existing 20-station (one of which is an isolation station) end-stage renal disease (ESRD) facility by adding 5 in-center hemodialysis stations for a total of 25 stations. Opposition: None
Approved
- AL2015-021:Oaks on Parkwood, LLC, proposes to expand its existing specialty care assisted living facility (SCALF) by adding 16 SCALF beds for a total of 50 SCALF beds. Opposition:None
Approved
- Reviewability Determinations and Pending Reviewability Determinations
- Reviewability Determinations
RV2015-022:Mobile Real Estate, LLC, requests to purchase from Crowne Health Care of Mobile, LLC, the fee ownership of the land, building, fixed assets, and certain personal property known as Crowne Health Care of Mobile, LLC, and that Crowne Health Care will continue to be the licensee and operator. Status: Non-Reviewable
RV2015-023:Comfort Care Home Health requests to establish a home health agency drop site in Tuscaloosa County. Status: Non-Reviewable
RV2015-024:Golden Living Center Montgomery requests to provide outpatient physical therapy only. Status: Non-Reviewable
- Pending Reviewability Determinations
RV2014-028:Surgicare of Mobile, Ltd., requests to add five operating rooms, 20 pre-/post-op bays, and four restrooms and expand the waiting room and business office. Status: Pending
Opposition: Providence Hospital filed a letter opposing the Reviewability Determination Request. Mobile Infirmary Association, d/b/a Mobile Infirmary Medical Center, filed a letter opposing the Reviewability Determination Request. In litigation, CV2014-901553, Springhill Hospitals, Inc., filed a Complaint for Declaratory Judgment and Injunctive Relief.
RV2015-018:Regional Health Management Corporation requests to lease space to operate two physicians’ offices and then sublease to RMC-Anniston for operation of a hospital-based diagnostic imaging center offering MRI, CT, general radiology, and ultrasound. Status: Pending
RV2015-020:Southern Alabama Surgery Center, LLC, d/b/a Surgery Center South, requests to expand the existing surgery center by leasing 7,569 square feet of shell space adjacent to the existing ASC space, within which Surgery Center South proposes to construct six additional operating rooms, two of which will be licensed, certified, fully staffed, and operated immediately upon completion of the construction, and four of which will remain unstaffed and held for future use. The leased space will also include 16 bays for pre-operative and recovery care, counseling space, a cleaning station, a waiting area, restrooms, and a small physicians’ lounge. Status: Pending
Opposition: Southeast Alabama Medical Center and Dothan Surgery Center, LLC RV2015-025:Charlton Place Rehabilitation and Healthcare requests to provide outpatient physical therapy services. Status: Pending
RV2015-026:Highlands Health & Rehab requests to replace the existing 50-bed nursing home in Scottsboro, AL. Status: Pending
RV2015-027:Bio-Medical Applications of Alabama, Inc. d/b/a Fresenius Medical Care Enterprise requests to establish a new ESRD center consisting of 10 hemodialysis stations in Coffee County. Status: Pending
RV2015-028:Bio-Medical Applications of Alabama, Inc., d/b/a FMC Dothan, requests to establish a new ESRD center consisting of 10 hemodialysis stations in Houston County. Status: Pending
RV2015-029:Bio-Medical Applications of Alabama, Inc., d/b/a FMC Decatur, requests to establish a new ESRD center consisting of 10 hemodialysis stations in Morgan County. Status: Pending
The next CON Review Board meeting will be held on July 15, 2015.
|
|
Rockwell Medical, Inc. Short Interest Update - Insider Trading Report |
Rockwell Medical, Inc. (NASDAQ:RMTI), A rise of 53,977 shares or 0.5% was seen in the short interest of Rockwell Medical, Inc. Even as the interest increased from 11,430,065 shares on May 29,2015 to 11,484,042 shares on June 15,2015, the days to cover came in at 16. The updated interest stood at 24.4% of the stocks floats. The shares has an average daily volume of 736,707 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th.
The company shares have shown gains of 26.08% in the past 52 Weeks. On June 16, 2015 The shares registered one year high of $15.04 and one year low was seen on December 15, 2014 at $8.1. The 50-day moving average is $11.47 and the 200 day moving average is recorded at $10.55. S&P 500 has rallied 8.87% during the last 52-weeks. Rockwell Medical, Inc. (NASDAQ:RMTI) : On Wednesday heightened volatility was witnessed in Rockwell Medical, Inc. (NASDAQ:RMTI) which led to swings in the share price. The shares opened for trading at $14.94 and hit $16.69 on the upside , eventually ending the session at $16.64, with a gain of 11.3% or 1.69 points. The heightened volatility saw the trading volume jump to 2,722,790 shares. The 52-week high of the share price is $15.04 and the company has a market cap of $835 million. The 52-week low of the share price is at $8.095 .
Rockwell Medical, Inc., formerly Rockwell Medical Technologies, Inc., manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Asia, Latin America and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys also known as End Stage Renal Disease (ESRD). ESRD is an advanced-stage of chronic kidney disease (CKD) characterized by the irreversible loss of kidney function. Its dialysis solutions (also known as dialysate) are used to maintain life, removing toxins and replacing nutrients in the dialysis patients bloodstream. As of December 31, 2011, it was licensed and was developing renal drug therapies. During the year ended December 31, 2011, it acquired an abbreviated new drug application (ANDA) for a generic version of an intravenous Vitamin-D analogue, calcitriol.
|
Moody's affirms U.S. Renal's B2 CFR; outlook changed to stable from negative - Moodys.com (press release) (subscription) |
© 2015 Moody’s Corporation, Moody’s Investors Service, Inc., Moody’s Analytics, Inc. and/or their licensors and affiliates (collectively, “MOODY’S”). All rights reserved.
CREDIT RATINGS ISSUED BY MOODY'S INVESTORS SERVICE, INC. AND ITS RATINGS AFFILIATES (“MIS”) ARE MOODY’S CURRENT OPINIONS OF THE RELATIVE FUTURE CREDIT RISK OF ENTITIES, CREDIT COMMITMENTS, OR DEBT OR DEBT-LIKE SECURITIES, AND CREDIT RATINGS AND RESEARCH PUBLICATIONS PUBLISHED BY MOODY’S (“MOODY’S PUBLICATIONS”) MAY INCLUDE MOODY’S CURRENT OPINIONS OF THE RELATIVE FUTURE CREDIT RISK OF ENTITIES, CREDIT COMMITMENTS, OR DEBT OR DEBT-LIKE SECURITIES. MOODY’S DEFINES CREDIT RISK AS THE RISK THAT AN ENTITY MAY NOT MEET ITS CONTRACTUAL, FINANCIAL OBLIGATIONS AS THEY COME DUE AND ANY ESTIMATED FINANCIAL LOSS IN THE EVENT OF DEFAULT. CREDIT RATINGS DO NOT ADDRESS ANY OTHER RISK, INCLUDING BUT NOT LIMITED TO: LIQUIDITY RISK, MARKET VALUE RISK, OR PRICE VOLATILITY. CREDIT RATINGS AND MOODY’S OPINIONS INCLUDED IN MOODY’S PUBLICATIONS ARE NOT STATEMENTS OF CURRENT OR HISTORICAL FACT. MOODY’S PUBLICATIONS MAY ALSO INCLUDE QUANTITATIVE MODEL-BASED ESTIMATES OF CREDIT RISK AND RELATED OPINIONS OR COMMENTARY PUBLISHED BY MOODY’S ANALYTICS, INC. CREDIT RATINGS AND MOODY’S PUBLICATIONS DO NOT CONSTITUTE OR PROVIDE INVESTMENT OR FINANCIAL ADVICE, AND CREDIT RATINGS AND MOODY’S PUBLICATIONS ARE NOT AND DO NOT PROVIDE RECOMMENDATIONS TO PURCHASE, SELL, OR HOLD PARTICULAR SECURITIES. NEITHER CREDIT RATINGS NOR MOODY’S PUBLICATIONS COMMENT ON THE SUITABILITY OF AN INVESTMENT FOR ANY PARTICULAR INVESTOR. MOODY’S ISSUES ITS CREDIT RATINGS AND PUBLISHES MOODY’S PUBLICATIONS WITH THE EXPECTATION AND UNDERSTANDING THAT EACH INVESTOR WILL, WITH DUE CARE, MAKE ITS OWN STUDY AND EVALUATION OF EACH SECURITY THAT IS UNDER CONSIDERATION FOR PURCHASE, HOLDING, OR SALE.
MOODY’S CREDIT RATINGS AND MOODY’S PUBLICATIONS ARE NOT INTENDED FOR USE BY RETAIL INVESTORS AND IT WOULD BE RECKLESS FOR RETAIL INVESTORS TO CONSIDER MOODY’S CREDIT RATINGS OR MOODY’S PUBLICATIONS IN MAKING ANY INVESTMENT DECISION. IF IN DOUBT YOU SHOULD CONTACT YOUR FINANCIAL OR OTHER PROFESSIONAL ADVISER.
ALL INFORMATION CONTAINED HEREIN IS PROTECTED BY LAW, INCLUDING BUT NOT LIMITED TO, COPYRIGHT LAW, AND NONE OF SUCH INFORMATION MAY BE COPIED OR OTHERWISE REPRODUCED, REPACKAGED, FURTHER TRANSMITTED, TRANSFERRED, DISSEMINATED, REDISTRIBUTED OR RESOLD, OR STORED FOR SUBSEQUENT USE FOR ANY SUCH PURPOSE, IN WHOLE OR IN PART, IN ANY FORM OR MANNER OR BY ANY MEANS WHATSOEVER, BY ANY PERSON WITHOUT MOODY’S PRIOR WRITTEN CONSENT.
All information contained herein is obtained by MOODY’S from sources believed by it to be accurate and reliable. Because of the possibility of human or mechanical error as well as other factors, however, all information contained herein is provided “AS IS” without warranty of any kind. MOODY'S adopts all necessary measures so that the information it uses in assigning a credit rating is of sufficient quality and from sources MOODY'S considers to be reliable including, when appropriate, independent third-party sources. However, MOODY’S is not an auditor and cannot in every instance independently verify or validate information received in the rating process or in preparing the Moody’s Publications.
To the extent permitted by law, MOODY’S and its directors, officers, employees, agents, representatives, licensors and suppliers disclaim liability to any person or entity for any indirect, special, consequential, or incidental losses or damages whatsoever arising from or in connection with the information contained herein or the use of or inability to use any such information, even if MOODY’S or any of its directors, officers, employees, agents, representatives, licensors or suppliers is advised in advance of the possibility of such losses or damages, including but not limited to: (a) any loss of present or prospective profits or (b) any loss or damage arising where the relevant financial instrument is not the subject of a particular credit rating assigned by MOODY’S.
To the extent permitted by law, MOODY’S and its directors, officers, employees, agents, representatives, licensors and suppliers disclaim liability for any direct or compensatory losses or damages caused to any person or entity, including but not limited to by any negligence (but excluding fraud, willful misconduct or any other type of liability that, for the avoidance of doubt, by law cannot be excluded) on the part of, or any contingency within or beyond the control of, MOODY’S or any of its directors, officers, employees, agents, representatives, licensors or suppliers, arising from or in connection with the information contained herein or the use of or inability to use any such information.
NO WARRANTY, EXPRESS OR IMPLIED, AS TO THE ACCURACY, TIMELINESS, COMPLETENESS, MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE OF ANY SUCH RATING OR OTHER OPINION OR INFORMATION IS GIVEN OR MADE BY MOODY’S IN ANY FORM OR MANNER WHATSOEVER.
Moody’s Investors Service, Inc., a wholly-owned credit rating agency subsidiary of Moody’s Corporation (“MCO”), hereby discloses that most issuers of debt securities (including corporate and municipal bonds, debentures, notes and commercial paper) and preferred stock rated by Moody’s Investors Service, Inc. have, prior to assignment of any rating, agreed to pay to Moody’s Investors Service, Inc. for appraisal and rating services rendered by it fees ranging from $1,500 to approximately $2,500,000. MCO and MIS also maintain policies and procedures to address the independence of MIS’s ratings and rating processes. Information regarding certain affiliations that may exist between directors of MCO and rated entities, and between entities who hold ratings from MIS and have also publicly reported to the SEC an ownership interest in MCO of more than 5%, is posted annually at www.moodys.com under the heading “Investor Relations — Corporate Governance — Director and Shareholder Affiliation Policy.”
For Australia only: Any publication into Australia of this document is pursuant to the Australian Financial Services License of MOODY’S affiliate, Moody’s Investors Service Pty Limited ABN 61 003 399 657AFSL 336969 and/or Moody’s Analytics Australia Pty Ltd ABN 94 105 136 972 AFSL 383569 (as applicable). This document is intended to be provided only to “wholesale clients” within the meaning of section 761G of the Corporations Act 2001. By continuing to access this document from within Australia, you represent to MOODY’S that you are, or are accessing the document as a representative of, a “wholesale client” and that neither you nor the entity you represent will directly or indirectly disseminate this document or its contents to “retail clients” within the meaning of section 761G of the Corporations Act 2001. MOODY’S credit rating is an opinion as to the creditworthiness of a debt obligation of the issuer, not on the equity securities of the issuer or any form of security that is available to retail clients. It would be dangerous for “retail clients” to make any investment decision based on MOODY’S credit rating. If in doubt you should contact your financial or other professional adviser.
For Japan only: MOODY'S Japan K.K. (“MJKK”) is a wholly-owned credit rating agency subsidiary of MOODY'S Group Japan G.K., which is wholly-owned by Moody’s Overseas Holdings Inc., a wholly-owned subsidiary of MCO. Moody’s SF Japan K.K. (“MSFJ”) is a wholly-owned credit rating agency subsidiary of MJKK. MSFJ is not a Nationally Recognized Statistical Rating Organization (“NRSRO”). Therefore, credit ratings assigned by MSFJ are Non-NRSRO Credit Ratings. Non-NRSRO Credit Ratings are assigned by an entity that is not a NRSRO and, consequently, the rated obligation will not qualify for certain types of treatment under U.S. laws. MJKK and MSFJ are credit rating agencies registered with the Japan Financial Services Agency and their registration numbers are FSA Commissioner (Ratings) No. 2 and 3 respectively.
MJKK or MSFJ (as applicable) hereby disclose that most issuers of debt securities (including corporate and municipal bonds, debentures, notes and commercial paper) and preferred stock rated by MJKK or MSFJ (as applicable) have, prior to assignment of any rating, agreed to pay to MJKK or MSFJ (as applicable) for appraisal and rating services rendered by it fees ranging from JPY200,000 to approximately JPY350,000,000.
MJKK and MSFJ also maintain policies and procedures to address Japanese regulatory requirements.
|
Thompson selected as new WCHCS dialysis director - Centerville Daily Iowegian |
Picasa
Thompson selected as new WCHCS dialysis director
Submitted photoAngie Thompson, RN
Posted: Wednesday, June 24, 2015 3:12 pm
Thompson selected as new WCHCS dialysis director
CORYDON — Wayne County Hospital and Clinic System is pleased to announce Angie Thompson, RN has been chosen as the new director of the Susie B. Tuttle Dialysis Unit. Thompson succeeds former director Maggie Lindsey, RN who moved into the position of WCHCS Specialty Clinic director.
“We are very pleased have someone with Angie’s qualifications and capability assume this position. She has tremendous experience and understands the intricacies of managing a dialysis unit,” commented Sheila Mattly, CNO.
Originally, from Nebraska, Angie has worked as a dialysis nurse for eight years. She started as a staff nurse in Council Bluffs, Iowa for three years, moving into a charge nurse position in Harlan, Iowa which she also held for three years. She then accepted a temporary position as the clinical nurse manager for the Omaha Tribe of Nebraska until a Native American was found to fill the position. Angie comes experienced in all facets of dialysis patient care and staff management. Her most recent position was as a traveling dialysis nurse in the state of Florida. She is pleased to now be working close to home.
Angie’s husband also works in dialysis, on the biomed side, and was recently transferred to the Centerville and Ottumwa units prompting their relocation from Onawa, Iowa to Centerville, Iowa. They have seven grown children and are empty nesters. They are enjoying five grandchildren with more expected to follow. Angie’s personal talents include singing and playing guitar.
Angie received her Associates of Arts and Sciences degree in nursing from Northeast Community College, Norfolk, Nebraska. She is a member of Phi Beta Kappa National Honor Society.
With your existing account from...
{* loginWidget *}
With a traditional account...
{* #userInformationForm *} {* traditionalSignIn_emailAddress *} {* traditionalSignIn_password *} {* traditionalSignIn_signInButton *}{* traditionalSignIn_createButton *} {* /userInformationForm *}
Welcome back, {* welcomeName *}!
{* loginWidget *}
Welcome back!
{* #userInformationForm *} {* traditionalSignIn_emailAddress *} {* traditionalSignIn_password *} {* traditionalSignIn_signInButton *} {* /userInformationForm *}
We have sent a confirmation email to {* emailAddressData *}. Please check your email and click on the link to activate your account.
We'll send you a link to create a new password.
{* #forgotPasswordForm *} {* traditionalSignIn_emailAddress *} {* backButton *} {* forgotPassword_sendButton *} {* /forgotPasswordForm *}
We've sent an email with instructions to create a new password. Your existing password has not been changed.
{* mergeAccounts *} {* #tradAuthenticateMergeForm *} {* traditionalSignIn_emailAddress *} {* mergePassword *} {* backButton *} {* traditionalSignIn_signInButton *} {* /tradAuthenticateMergeForm *}
Posted in Local news on Wednesday, June 24, 2015 3:12 pm.
|
Days After Refusing 'Dog Dialysis', Chief of Kolkata's Premier Hospital ... - NDTV |
Kolkata: The director of West Bengal's top government-run post graduate medical college and hospital, SSKM, has applied for voluntary retirement after being summarily transferred from the post.
Dr Pradip Mitra says he has been humiliated and insulted. He doesn't know for what, but does not rule out the possibility of being punished for stopping the dialysis of a dog at the premier hospital on June 10.
The dog was allegedly sent for treatment at the hospital by Trinamool Congress leader Dr Nirmal Majhi, who heads the state medical council. There is no facility for veterinary dialysis in Kolkata.
When the matter was first reported, Trinamool's Nirmal Majhi was quoted saying, "It was a cute dog. It was suffering. So why not treat it?" But on Wednesday, when contacted over phone, Dr Majhi said, "I have nothing to do with any dog. The report is planted to defame me."
The dog was almost admitted, on the orders of the head of the nephrology department, Dr Rajen Pandey who was out of town on that day but apparently telephoned orders to his juniors to conduct the procedure.
Dr Pandey also texted Dr Mitra that "VIP dog dialysis required. Vet of govt hospital has approached me."
"Soon after, I was contacted by a senior nephrologist, Dr Aprita Roy Chowdury, who said a 'dog dialysis' is going to be held at the hospital. I was surprised," said Dr Mitra. "Immediately, I ordered that it should be stopped. I asked who ordered it, and was told that the head of the department ordered some persons and it has been registered in the log book."
Hospital sources confirm that the dialysis unit's log book has an entry, number 13, for "unknown dog" on June 10.
Thirteen days later, on June 23, Dr Mitra was summarily transferred, given his release papers and replaced.
Health officials insist it is a routine transfer. But Dr Mitra, who has been in the state health service for 33 years, says such summary transfer is highly unusual.
"This happens only if there is some mischief and complaint against a person. In such cases it is done. It is not routine, even though they are saying it is a routine transfer. This has not been done before," he said. Mr Mitra had served as the director of SSKM for over seven years.
Dr Mitra asked the government to probe the "dog dialysis" incident. But it is yet to be done.
Now posted to a fledgling medical college, he has applied for voluntary retirement. Asked why he didn't appeal to the Chief Minister, he said, his transfer could not have happened without her consent. Mamata Banerjee also holds the health portfolio.
|
|
|